Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Non-Current Assets (2021 - 2025)

LifeStance Health (LFST) has disclosed Non-Current Assets for 5 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 1.0% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a 1.0% decrease, with the full-year FY2025 number at $1.8 billion, down 1.0% from a year prior.
  • Non-Current Assets was $1.8 billion for Q4 2025 at LifeStance Health, roughly flat from $1.8 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.9 billion in Q1 2023 to a low of $1.6 billion in Q2 2021.
  • A 5-year average of $1.8 billion and a median of $1.8 billion in 2025 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: grew 16.87% in 2022, then fell 4.73% in 2024.
  • LifeStance Health's Non-Current Assets stood at $1.7 billion in 2021, then rose by 16.87% to $1.9 billion in 2022, then dropped by 2.91% to $1.9 billion in 2023, then fell by 4.16% to $1.8 billion in 2024, then decreased by 1.0% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for LFST's Non-Current Assets are $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.8 billion (Q2 2025).